Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2076
Nabors Industries
NBR
$1.22B
| $1.45M | ﹤0.01% |
16,800
+11,800
| +236% | +$856K |
2025 Q3
2 quarters
|
|
2077
Delcath Systems
DCTH
$532M
| $1.44M | ﹤0.01% |
155,300
-206,299
| -57% | -$2M |
2024 Q2
7 quarters
|
|
2078
DELISTED
Udemy
UDMY
| $1.44M | ﹤0.01% |
311,901
-117,600
| -27% | -$580K |
2024 Q2
7 quarters
|
|
2079
Surrozen
SRZN
$276M
| $1.43M | ﹤0.01% |
49,126
+26,500
| +117% | +$635K |
2022 Q4
13 quarters
|
|
2080
JPMorgan Municipal ETF
JMUB
$8.54B
| $1.43M | ﹤0.01% |
28,600
-57,200
| -67% | -$2.9M |
2023 Q4
9 quarters
|
|
2081
NBT Bancorp
NBTB
$2.61B
| $1.43M | ﹤0.01% |
33,473
-28,300
| -46% | -$1.23M |
2024 Q1
8 quarters
|
|
2082
Copel
ELPC
$10.4B
| $1.43M | ﹤0.01% |
119,359
-271,633
| -69% | -$2.89M |
2025 Q4
1 quarter
|
|
2083
1stdibs.com
DIBS
$128M
| $1.42M | ﹤0.01% |
258,500
-82,100
| -24% | -$455K |
2022 Q1
16 quarters
|
|
2084
Eagle Bancorp Montana
EBMT
$166M
| $1.42M | ﹤0.01% |
69,010
-400
| -0.6% | -$8.53K |
2016 Q4
37 quarters
|
|
2085
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
| $1.42M | ﹤0.01% |
29,800
+6,300
| +27% | +$306K |
2023 Q2
11 quarters
|
|
2086
Morgan Stanley Direct Lending Fund
MSDL
$1.11B
| $1.42M | ﹤0.01% |
101,429
-32,071
| -24% | -$496K |
2024 Q3
6 quarters
|
|
2087
Hyster-Yale Materials Handling
HY
$573M
| $1.41M | ﹤0.01% |
43,400
+3,500
| +9% | +$120K |
2023 Q1
12 quarters
|
|
2088
Deluxe
DLX
$1.06B
| $1.41M | ﹤0.01% |
+51,230
| New | +$1.34M |
2026 Q1
0 quarters
|
|
2089
908 Devices
MASS
$500M
| $1.41M | ﹤0.01% |
230,200
+8,100
| +4% | +$50.7K |
2022 Q1
16 quarters
|
|
2090
Rallybio
RLYB
$88.8M
| $1.4M | ﹤0.01% |
156,527
+52,065
| +50% | +$356K |
2024 Q1
8 quarters
|
|
2091
Senstar Technologies
SNT
$33.4M
| $1.4M | ﹤0.01% |
462,969
-12,300
| -3% | -$45.3K |
2013 Q2
51 quarters
|
|
2092
MaxCyte
MXCT
$99.5M
| $1.4M | ﹤0.01% |
1,993,200
+1,206,300
| +153% | +$1.13M |
2023 Q1
12 quarters
|
|
2093
DELISTED
Kezar Life Sciences
KZR
| $1.4M | ﹤0.01% |
188,426
+57,141
| +44% | +$372K |
2019 Q3
26 quarters
|
|
2094
Ingredion
INGR
$6.13B
| $1.4M | ﹤0.01% |
12,400
-3,500
| -22% | -$402K |
2024 Q1
8 quarters
|
|
2095
First Trust Global Tactical Commodity Strategy Fund
FTGC
$3.42B
| $1.4M | ﹤0.01% |
48,600
+11,500
| +31% | +$297K |
2024 Q3
6 quarters
|
|
2096
Karooooo
KARO
$1.9B
| $1.39M | ﹤0.01% |
27,987
+400
| +1% | +$18.9K |
2023 Q3
10 quarters
|
|
2097
Evolus
EOLS
$496M
| $1.39M | ﹤0.01% |
339,025
-460,875
| -58% | -$2.23M |
2025 Q1
4 quarters
|
|
2098
ReNew
RNW
$2.51B
| $1.39M | ﹤0.01% |
302,800
-7,200
| -2% | -$38.3K |
2025 Q1
4 quarters
|
|
2099
Aebi Schmidt Holding AG
AEBI
$872M
| $1.38M | ﹤0.01% |
142,200
+59,000
| +71% | +$809K |
2025 Q3
2 quarters
|
|
2100
Vanguard Extended Market ETF
VXF
$30.3B
| $1.38M | ﹤0.01% |
6,700
+1,700
| +34% | +$364K |
2025 Q3
2 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.